Wildon Farwell, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 4,337 shares at $28.20 ($122K) on 2024-05-16, disclosed to the SEC on 2024-05-17.
Scheduled sale ($122k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.20 | 1,956 | $55K | 45.0% |
| 2 | $28.20 | 1,956 | $55K | 45.0% |
| 3 | $28.59 | 425 | $12K | 9.9% |
| Total | $28.24 avg | 4,337 | $122K | 100% |
| Filing → |
| DYN | SELL | 2024-03-12 | $67K | — | Filing → |
| DYN | SELL | 2024-03-11 | $472K | — | Filing → |
| DYN | SELL | 2024-02-28 | $10K | — | Filing → |